Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hyliion Holdings Corp. Class A Common Stock (NY:HYLN)

1.290 -0.020 (-1.53%)
Official Closing Price Updated: 8:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hyliion Holdings Corp. Class A Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Hyliion Holdings Stock Isn’t as Cheap as It Looks as Costs Rise and Hope Fades
Trouble continues to compound for HYLN stock as SPAC hype fades. The company is predicting much greater results than anyone else. 
Via InvestorPlace
Nothing Suggests Hyliion Stock Can Charge Back Up to Past Prices
As it falls short of expectations, and with more signs of it floundering further, it's best to stay away from HYLN stock. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Is Hyliion Stock a Buy?
The electric powertrain provider faces multiple challenges. 
Via The Motley Fool
Hyliion Names Shiva Duraiswamy as Vice President of Engineering
From Hyliion Holdings Corp.
Via Business Wire
Hyliion Holdings Schedules Third Quarter 2021 Financial Results Conference Call and Webcast for November 10, 2021
From Hyliion Holdings Corp.
Via Business Wire
4 Reasons Why Bears May Be Underestimating Hyliion Stock
Firms want to get greener, and Hyliion's solutions have some meaningful advantages Some investors should consider buying HYLN stock. 
Via InvestorPlace
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Toward the end of trading on Monday, the Dow traded down 0.37% to 34,617.17 while the Nasdaq fell 0.05% to 34,617.14. The S&P 500 also fell, dropping 0.26% to 4,379.88. Let's look at what has happened... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
10 Industrials Stocks Moving In Monday's Intraday Session
Gainers Akerna (NASDAQ:KERN) shares rose 11.85% to $3.02 during Monday's regular session. As of 12:30 EST, Akerna's stock is trading at a volume of 943.9K, which... 
Via Benzinga
HYLN Stock: Why EV Play Hyliion Holdings Is Taking a Huge Hit Today
Hyliion Holdings (HYLN) stock is taking a beating on Monday and it's thanks to an analyst weighing in on the electric vehicle (EV) company. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Analyst Says Sell This Electric Truck Hopeful Before It Misses Expectations
The analyst believes HYLN is not going to meet revenue expectations for 2022 through 2024, which is a key valuation driver. Hyliion, along with other EVs startups, has dealt with commercialization... 
Via Talk Markets
Topics Electric Vehicles
Exposures Electric Vehicles
Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals
Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
28 Stocks Moving In Monday's Mid-Day Session
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ: 
Via Benzinga
Why Hyliion Shares Are Falling
Hyliion Holdings Corp (NYSE: HYLN) shares are trading lower by 12.9% at $6.82 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $14 ... 
Via Benzinga
Why Hyliion Holdings Stock Is Falling Today
The once-promising start-up may have missed its window of opportunity. 
Via The Motley Fool
10 Biggest Price Target Changes For Monday
Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (... 
Via Benzinga
Hyliion Holdings Is a Risky Long-Term Bet
It’s been downhill for HYLN stock since last fall with competition from EV and traditional truck makers threatening growth propositions. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Hyliion Commercialization Should Offer Catalyst To Reverse 50% Share Drop
Despite HYLN stock underperforming, there have been new developments in Hyliion. These developments include a new COO and new orders from a major customer. 
Via InvestorPlace
Why the Infrastructure Bill Has These 3 Stocks Soaring Today
A vote on the bipartisan infrastructure bill is scheduled for this Thursday in the House of Representatives. 
Via The Motley Fool
Topics Electric Vehicles
Exposures Electric Vehicles
HYLN Stock: Why Is EV Startup Hyliion Revving Up Today?
Today, investors in Hyliion and HYLN stock are seeing impressive gains as sentiment in the EV sector becomes bullish once again. 
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
These 3 EV Stocks Are Down 30% or More This Year. Time to Buy?
Are the stocks for these electric vehicle-focused companies bargain picks or is there a reason for the fall? 
Via The Motley Fool
Innovative Hyliion Depends Heavily on a SPAC Revival
Stuck in a funk, HYLN stock needs another boost in the SPAC arena. However, this doesn’t look to be coming anytime soon. 
Via InvestorPlace
ADDING MULTIMEDIA Hyliion® Announces Launch of Improved Hybrid Powertrain Solution – “Hybrid eX”
From Hyliion
Via Business Wire
Hyliion Unveils Hybrid Powertrain System: What Investors Should Know
Class 8 commercial semi-truck company Hyliion Holdings Corp (NYSE: HYLN) announced Tuesday morning the debut of Hyliion Hybrid eX, an enhanced version of the... 
Via Benzinga
Hyliion® Announces Launch of Improved Hybrid Powertrain Solution – “Hybrid eX”
From Hyliion
Via Business Wire
Truck Talk: Throwing Shade Edition
This week, Plus CEO David Liu talks about autonomous trucking in China; debating the limitations of real-world autonomous miles versus simulations; and hybrid powertrain maker... 
Via Benzinga
Hyliion Announces Automotive Industry Veteran Mary Gustanski to Join Board of Directors
From Hyliion Holdings Corp.
Via Business Wire
Hyliion Announces Former Secretary Elaine Chao to Join Board of Directors
From Hyliion Holdings Corp.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.